BIOMAT Database Logo BIOMAT Database Logo

[Synthesis of 1-butyl-3,5-bis-(pyridinemethyl)-piperidone-4 and 1-butyl-3,5-bis-(4-pyridinemethyl)-piperidone-4]. 1973

B Gutkowska

UI MeSH Term Description Entries
D010880 Piperidines A family of hexahydropyridines.
D010881 Piperidones A family of saturated heterocyclic organic compounds which contain one nitrogen atom and a carbonyl group in the ring structure. Piperidone
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D013055 Spectrophotometry, Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) IR Spectra,Infrared Spectrophotometry,IR Spectras,Spectra, IR

Related Publications

B Gutkowska
3,5-bis[4-(diethylamino)benzylidene]-1-methyl-4-piperidone and 3,5-bis[4-(diethylamino)cinnamylidene]-1-methyl-4-piperidone: prospective biophotonic materials.
November 2003, Acta crystallographica. Section C, Crystal structure communications,
B Gutkowska
[Synthesis of antiproteolytically active 3,5-bis(4-amidinobenzyl)- and 3,5-bis(4-amidinobenzylidene)piperidone-(4) derivatives (author's transl)].
February 1980, Die Pharmazie,
B Gutkowska
1-Benzyl-3,5-bis-(2-thienylmethyl-ene)-4-piperidone.
September 2009, Acta crystallographica. Section E, Structure reports online,
B Gutkowska
3,5-Bis(4-methoxybenzylidene)-1-methyl-4-piperidone and 3,5-bis(4-methoxybenzylidene)-1-methyl-4-oxopiperidinium chloride: potential biophotonic materials.
November 2004, Acta crystallographica. Section C, Crystal structure communications,
B Gutkowska
3,5-Bis{3-[4-(dimethylamino)phenyl]prop-2-enylidene}-1-methyl-4-piperidone and 3,5-bis[3-(4-methoxyphenyl)prop-2-enylidene]-1-methyl-4-piperidone: potential biophotonic materials.
February 2008, Acta crystallographica. Section C, Crystal structure communications,
B Gutkowska
From small structural modifications to adjustment of structurally dependent properties: 1-methyl-3,5-bis[(E)-2-thienylidene]-4-piperidone and 3,5-bis[(E)-5-bromo-2-thienylidene]-1-methyl-4-piperidone.
April 2009, Acta crystallographica. Section C, Crystal structure communications,
B Gutkowska
Treatment of rheumatoid arthritis with curcumin analog 3,5-bis(arylidene)-4-piperidone.
November 2023, Future medicinal chemistry,
B Gutkowska
Synthesis, crystal structures and anti-inflammatory activity of four 3,5-bis(arylidene)-N-benzenesulfonyl-4-piperidone derivatives.
October 2018, Acta crystallographica. Section C, Structural chemistry,
B Gutkowska
Synthesis and biological testing of 3,5-bis(arylidene)-4-piperidone conjugates with 2,5-dihydro-5H-1,2-oxaphospholenes.
October 2022, Bioorganic & medicinal chemistry letters,
B Gutkowska
Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts.
November 2021, Molecules (Basel, Switzerland),
Copied contents to your clipboard!